REQUEST A DEMO
Total
USD $0.00
Search more companies

Recombigen Laboratories Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Recombigen Laboratories Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Recombigen Laboratories Private Limited is an unlisted company, incorporated on 07/01/1999. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24231DL1999PTC097838 and registration number is 097838. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Prop. No. 98, Phase-Ii Badli Industrial Estate
North West Delhi; Delhi; Postal Code: 110042

Contact Details: Purchase the Recombigen Laboratories Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Recombigen Laboratories Private Limited report to view the information.
Outstanding Shares:
Purchase the Recombigen Laboratories Private Limited report to view the information.
Registered Capital:
Purchase the Recombigen Laboratories Private Limited report to view the information.
Incorporation Date:
January 07, 1999
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Recombigen Laboratories Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
4.59%
Total operating revenue
9.87%
Operating profit (EBIT)
8.25%
EBITDA
10.59%
Net Profit (Loss) for the Period
11.17%
Total assets
35.04%
Total equity
27.59%
Operating Profit Margin (ROS)
0.08%
Net Profit Margin
0.1%
Return on Equity (ROE)
-3.2%
Debt to Equity Ratio
225.7%
Quick Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?